Einloggen

Thematische Bibliographien / Genetic data / Zeitschriftenartikel

Zeitschriftenartikel zum Thema „Genetic data“

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Genetic data.

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 20. Februar 2023

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Genetic data" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Volkova, T., E. Furta, O. Dmitrieva und I. Shabalina. „Pattern Building Methods in Genetic Data Processing“. Journal on Selected Topics in Nano Electronics and Computing 1, Nr. 2 (Juni 2014): 2–6. http://dx.doi.org/10.15393/j8.art.2014.3041.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Taylor, Mark J. „Data Protection, Shared (Genetic) Data and Genetic Discrimination“. Medical Law International 8, Nr. 1 (Dezember 2006): 51–77. http://dx.doi.org/10.1177/096853320600800103.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Ross-Ibarra, Jeffrey. „Genetic Data Analysis II. Methods for Discrete Population Genentic Data“. Economic Botany 56, Nr. 2 (April 2002): 216. http://dx.doi.org/10.1663/0013-0001(2002)056[0216:gdaimf]2.0.co;2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Slatkin, Montgomery, Wayne P. Maddison und B. S. Weir. „Genetic Data Analysis: Methods for Discrete Population Genetic Data.“ Systematic Zoology 40, Nr. 2 (Juni 1991): 248. http://dx.doi.org/10.2307/2992265.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Chase, Gary A., und Bruce S. Weir. „Genetic Data Analysis: Methods for Discrete Population Genetic Data.“ Journal of the American Statistical Association 86, Nr. 413 (März 1991): 248. http://dx.doi.org/10.2307/2289745.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Feytmans, E., und B. S. Weir. „Genetic Data Analysis: Methods for Discrete Population Genetic Data.“ Biometrics 47, Nr. 3 (September 1991): 1205. http://dx.doi.org/10.2307/2532683.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Morton, N. E. „Genetic Data Analysis. Methods for Discrete Population Genetic Data“. Journal of Medical Genetics 29, Nr. 3 (01.03.1992): 216. http://dx.doi.org/10.1136/jmg.29.3.216.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Slatkin, M., und W. P. Maddison. „Genetic Data Analysis: Methods for Discrete Population Genetic Data“. Systematic Biology 40, Nr. 2 (01.06.1991): 248–49. http://dx.doi.org/10.1093/sysbio/40.2.248.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Butler, Amy W., Sarah Cohen-Woods, Anne Farmer, Peter McGuffin und Cathryn M. Lewis. „Integrating Phenotypic Data For Depression“. Journal of Integrative Bioinformatics 7, Nr. 3 (01.12.2010): 290–99. http://dx.doi.org/10.1515/jib-2010-136.

Der volle Inhalt der Quelle

Annotation:

Abstract The golden era of molecular genetic research brings about an explosion of phenotypic, genotypic and sequencing data. Building on the common aims to exploit understanding of human diseases, it also opens up an opportunity for scientific communities to share and combine research data. Genome-wide association studies (GWAS) have been widely used to locate genetic variants, which are susceptible for common diseases. In the field of medical genetics, many international collaborative consortiums have been established to conduct meta-analyses of GWAS results and to combine large genotypic data sets to perform mega genetic analyses. Having an integrated phenotype database is significant for exploiting the full potential of extensive genotypic data. In this paper, we aim to share our experience gained from integrating four heterogeneous sets of major depression phenotypic data onto the MySQL platform. These data sets constitute clinical data which had been gathered for various genetic studies for the past decade. We also highlight in this report some generic data handling techniques, the costs and benefits regarding the use of integrated phenotype database within our own institution and under the consortium framework.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Uzych, Leo. „Genetic Testing Data“. Journal of Occupational & Environmental Medicine 38, Nr. 1 (Januar 1996): 13–14. http://dx.doi.org/10.1097/00043764-199601000-00001.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Rischitelli, Gary. „Genetic Testing Data“. Journal of Occupational & Environmental Medicine 38, Nr. 1 (Januar 1996): 14. http://dx.doi.org/10.1097/00043764-199601000-00002.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Ahluwalia, Maninder. „Protecting genetic data“. New Scientist 247, Nr. 3295 (August 2020): 23. http://dx.doi.org/10.1016/s0262-4079(20)31409-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

The Lancet Oncology. „Consolidating genetic data“. Lancet Oncology 6, Nr. 6 (Juni 2005): 351. http://dx.doi.org/10.1016/s1470-2045(05)70177-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Rutledge, Louis C. „Genetic Data Analysis“. Annals of the Entomological Society of America 84, Nr. 6 (01.11.1991): 639. http://dx.doi.org/10.1093/aesa/84.6.639a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Mick Richardson, P. „Genetic data analysis“. Biochemical Systematics and Ecology 18, Nr. 5 (August 1990): 387. http://dx.doi.org/10.1016/0305-1978(90)90013-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Lorey, Fred. „Human Genetics Data Applied to Genetic Screening Programs“. Practicing Anthropology 20, Nr. 2 (01.04.1998): 30–33. http://dx.doi.org/10.17730/praa.20.2.n84728r821185380.

Der volle Inhalt der Quelle

Annotation:

The uses of human genetic data in genetic screening are multifaceted and dynamic, creating an ongoing stream of useful prevalence data, ethnicity data, and natural history information. Since the primary facility for generation of these data is a large public health genetic screening program, however, the results must be continually analyzed and evaluated in the context of testing parameters. For example, presumptive positive rates (initial screening test positives, only a portion of which will become diagnosed cases), false positive rates, detection rates, and analytical values must be constantly checked to ensure the screening program is running smoothly and effectively. Any departures from the expected must be investigated so that the cause(s) can be determined and corrected. On a longitudinal basis, outcomes must be evaluated to ensure that the intended purpose of preventing mortality and reducing morbidity through intervention is achieved.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Weir, B. S. „Genetic Data Analysis II.“ Biometrics 53, Nr. 1 (März 1997): 392. http://dx.doi.org/10.2307/2533134.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Ott, Jurg. „Genetic data analysis II“. Trends in Genetics 13, Nr. 9 (September 1997): 379. http://dx.doi.org/10.1016/s0168-9525(97)81169-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Coupland, Robin, Sophie Martin und Maria-Teresa Dutli. „Protecting everybody's genetic data“. Lancet 365, Nr. 9473 (Mai 2005): 1754–56. http://dx.doi.org/10.1016/s0140-6736(05)66563-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Jorde, L. B. „Genetic Data Analysis: Methods for Discrete Population Genetic Data. Bruce S. Weir“. Quarterly Review of Biology 66, Nr. 4 (Dezember 1991): 488–89. http://dx.doi.org/10.1086/417362.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Spector-Bagdady, Kayte, Amanda Fakih, Chris Krenz, Erica E. Marsh und J. Scott Roberts. „Genetic data partnerships: academic publications with privately owned or generated genetic data“. Genetics in Medicine 21, Nr. 12 (17.06.2019): 2827–29. http://dx.doi.org/10.1038/s41436-019-0569-z.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Chikhi, L. „Genetic markers: How accurate can genetic data be?“ Heredity 101, Nr. 6 (01.10.2008): 471–72. http://dx.doi.org/10.1038/hdy.2008.106.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Deckard, Jamalynne, Clement J. McDonald und Daniel J. Vreeman. „Supporting interoperability of genetic data with LOINC“. Journal of the American Medical Informatics Association 22, Nr. 3 (05.02.2015): 621–27. http://dx.doi.org/10.1093/jamia/ocu012.

Der volle Inhalt der Quelle

Annotation:

Abstract Electronic reporting of genetic testing results is increasing, but they are often represented in diverse formats and naming conventions. Logical Observation Identifiers Names and Codes (LOINC) is a vocabulary standard that provides universal identifiers for laboratory tests and clinical observations. In genetics, LOINC provides codes to improve interoperability in the midst of reporting style transition, including codes for cytogenetic or mutation analysis tests, specific chromosomal alteration or mutation testing, and fully structured discrete genetic test reporting. LOINC terms follow the recommendations and nomenclature of other standards such as the Human Genome Organization Gene Nomenclature Committee’s terminology for gene names. In addition to the narrative text they report now, we recommend that laboratories always report as discrete variables chromosome analysis results, genetic variation(s) found, and genetic variation(s) tested for. By adopting and implementing data standards like LOINC, information systems can help care providers and researchers unlock the potential of genetic information for delivering more personalized care.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Suksut, Keerachart, Kittisak Kerdprasop und Nittaya Kerdprasop. „Support Vector Machine with Restarting Genetic Algorithm for Classifying Imbalanced Data“. International Journal of Future Computer and Communication 6, Nr. 3 (September 2017): 92–96. http://dx.doi.org/10.18178/ijfcc.2017.6.3.496.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Lyutov, N. L. „Genetic discrimination and protection of personal genetic data: Adapting legal standards to advances in genetics“. Journal of Physics: Conference Series 2210, Nr. 1 (01.03.2022): 012001. http://dx.doi.org/10.1088/1742-6596/2210/1/012001.

Der volle Inhalt der Quelle

Annotation:

Abstract Genetics has advanced to the point where genetic data on an individual could mark them as predisposed to hereditary illness or unsuitable for certain kinds of jobs. There is widespread apprehension that workers with ‘problematic’ genetics will be singled out by employers and insurance companies for treatment as second-class citizens with restrictions placed on their rights. The article takes up the legal issues involved in defining the concept of genetic data, in regulating genetic information as a type of personal information, and in applying genetic antidiscrimination laws in various countries. Legal restraints on genetic information must be more extensive than on other personal information about a worker because genetic data has implications for their biological relatives. Protection against genetic discrimination must therefore begin with barring employers from collecting genetic information on workers unless it is necessary to prevent hazards to people’s lives or health.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Atramentova, L., und H. Ehyakonandeh. „Molecular genetic data in terms of associative and population genetics“. 36, Nr. 36 (25.08.2021): 35–40. http://dx.doi.org/10.26565/2075-5457-2021-36-4.

Der volle Inhalt der Quelle

Annotation:

In studies on associative genetics of various multifactorial diseases, it is most often found that the minor allele’s frequency in the group of patients is higher than in the group of healthy people. Due to reduced adaptation, the minor allele manifests itself as a disease. In the group of patients, the number of homozygotes by major allele is reduced, the number of heterozygous carriers of the provocative allele is increased, and the frequency of homozygotes by the provocative allele is significantly increased. The aim of this article was to analyze the unusual result for SNP 1298A/C of the MTHFR gene in multiple sclerosis, previously obtained by one of the authors. The allele frequencies in the control group and in the group of multiple sclerosis do not differ, but the distribution of genotypes in the patients does not correspond to the Hardy–Weinberg ratio in compare to healthy people. Among patients, the number of heterozygotes is increased and the number of each homozygote is decreased. The increase in the proportion of heterozygotes can be explained by the presence of one provocative allele, but the large shortage of homozygotes for the minor allele is unclear. To explain this fact, the composition of the group of patients was analysed. The patients are of different ages, this group is heterogeneous in sex and form of multiple sclerosis, but none of these indicators has not be taken into account in the analysis of the distribution of genotypes. The age of the disease is a diagnostic sign and may depend on the genotype. The manifestation of multifactorial diseases depends on gender as well. Clinical forms of the disease usually have a different genetic basis. Due to the neglect of these conditions, a genetically heterogeneous group is formed, and any result, difficult for explanation, can be obtained. The lack of СС genotypes may be due to increased mortality, which reduces the probability of patients to be investigated in the sample. These facts once again indicate the need to form homogeneous groups for research on associative genetics.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Rajavarma, V. N., und S. P. Rajagopala. „Feature Selection in Data-Mining for Genetics Using Genetic Algorithm“. Journal of Computer Science 3, Nr. 9 (01.09.2007): 723–25. http://dx.doi.org/10.3844/jcssp.2007.723.725.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Greytak, Ellen M., David H. Kaye, Bruce Budowle, CeCe Moore und Steven L. Armentrout. „Privacy and genetic genealogy data“. Science 361, Nr. 6405 (30.08.2018): 857.1–857. http://dx.doi.org/10.1126/science.aav0330.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Židanavičiutė, J. „LOGIT ANALYSIS OF GENETIC DATA“. Mathematical Modelling and Analysis 13, Nr. 1 (31.03.2008): 135–44. http://dx.doi.org/10.3846/1392-6292.2008.13.135-144.

Der volle Inhalt der Quelle

Annotation:

A new framework of genetic sequence statistical analysis based on generalized logit model is introduced. Logit analysis is applied to assess the dependence structure (interactions) between DNA nucleotides and to test hypothesis about Markov order of these dependencies. The procedure proposed seeks the non‐coding subsequences which are homogeneous but yet non‐Markov. It has been shown, that even homogeneous DNA regions can not be treated as the first order Markov sequences.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Check Hayden, Erika. „Data barriers limit genetic diagnosis“. Nature 494, Nr. 7436 (Februar 2013): 156–57. http://dx.doi.org/10.1038/494156a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Elkan, C. „Access to genetic sequence data“. Science 255, Nr. 5045 (07.02.1992): 663. http://dx.doi.org/10.1126/science.1738833.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Lawson, Daniel John, und Daniel Falush. „Population Identification Using Genetic Data“. Annual Review of Genomics and Human Genetics 13, Nr. 1 (22.09.2012): 337–61. http://dx.doi.org/10.1146/annurev-genom-082410-101510.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Sariyar, Murat, Stephanie Suhr und Irene Schlünder. „How Sensitive Is Genetic Data?“ Biopreservation and Biobanking 15, Nr. 6 (01.12.2017): 494–501. http://dx.doi.org/10.1089/bio.2017.0033.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Drechsler, R., und N. Göckel. „Genetic algorithm for data sequencing“. Electronics Letters 33, Nr. 10 (1997): 843. http://dx.doi.org/10.1049/el:19970600.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Otlowski, Margaret F., Sandra D. Taylor und Kristine K. Barlow-Stewart. „Genetic discrimination: Too few data“. European Journal of Human Genetics 11, Nr. 1 (Januar 2003): 1–2. http://dx.doi.org/10.1038/sj.ejhg.5200910.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Bhasin, Harsh, und Neha Singla. „Cellular-genetic test data generation“. ACM SIGSOFT Software Engineering Notes 38, Nr. 5 (26.08.2013): 1–9. http://dx.doi.org/10.1145/2507288.2507303.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Sorani, Marco D., John K. Yue, Sourabh Sharma, Geoffrey T. Manley, Adam R. Ferguson, Shelly R. Cooper, Kristen Dams-O’Connor et al. „Genetic Data Sharing and Privacy“. Neuroinformatics 13, Nr. 1 (18.10.2014): 1–6. http://dx.doi.org/10.1007/s12021-014-9248-z.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Bowman, K. O., und M. A. Kastenbaum. „Overdispersion of aggregated genetic data“. Mutation Research/Environmental Mutagenesis and Related Subjects 272, Nr. 2 (Oktober 1992): 133–37. http://dx.doi.org/10.1016/0165-1161(92)90041-j.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Giles, Barbara E. „Genetic biodiversity: analysing the data“. Trends in Ecology & Evolution 9, Nr. 9 (September 1994): 317–19. http://dx.doi.org/10.1016/0169-5347(94)90150-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

S. Waples, Robin. „Guidelines for genetic data analysis“. J. Cetacean Res. Manage. 18, Nr. 1 (24.01.2023): 33–80. http://dx.doi.org/10.47536/jcrm.v18i1.421.

Der volle Inhalt der Quelle

Annotation:

The IWC Scientific Committee recently adopted guidelines for quality control of DNA data. Once data have been collected, the next step is to analyse the data and make inferences that are useful for addressing practical problems in conservation and management of cetaceans. This is a complex exercise, as numerous analyses are possible and users have a wide range of choices of software programs for implementing the analyses. This paper reviews the underlying issues, illustrates application of different types of genetic data analysis to two complex management problems (involving common minke whales and humpback whales), and concludes with a number of recommendations for best practices in the analysis of population genetic data. An extensive Appendix provides a detailed review and critique of most types of analyses that are used with population genetic data for cetaceans.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Yandell, Brian S. „Graphical Data Presentation, with Emphasis on Genetic Data“. HortScience 42, Nr. 5 (August 2007): 1047–51. http://dx.doi.org/10.21273/hortsci.42.5.1047.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Kuru, Taner, und Iñigo de Miguel Beriain. „Your genetic data is my genetic data: Unveiling another enforcement issue of the GDPR“. Computer Law & Security Review 47 (November 2022): 105752. http://dx.doi.org/10.1016/j.clsr.2022.105752.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Diaconescu, Ioana, und Sorin Hostiuc. „Pharmacogenomics: Ethical Issues in Data Management“. Studia Universitatis Babeş-Bolyai Bioethica 66, Special Issue (09.09.2021): 69. http://dx.doi.org/10.24193/subbbioethica.2021.spiss.40.

Der volle Inhalt der Quelle

Annotation:

"Pharmacogenomics uses a DNA sequence in order to create a “genetic map” that determines which drugs are the most efficient for a specific disease, in a particular patient. The needed information for developing personalized therapies needs, besides genetic data, various non-genetic factors might interfere with some mechanisms of drug action, and they should also be considered. The assumption that the genetic data is more important than any other type of non-genetic medical information may severely alter the reliability of pharmacogenomics. In order to decrease the risk for non-genetic factors to significantly alter the pharmacogenomics-related therapies, patients need to provide detailed information about them. This, however, is often not specifically sought upon by neither the patient (who sees this information as trivial when the physician interacts directly with her/his genes), nor the physician (who is often a genetics/ pharmacogenetics expert, who tends to see the genetic information as supreme). One of the main targets in data management is privacy. A lot of effort is needed to keep the data anonymous and creating a detailed informed consent to determine the patient to acknowledge the risks and the benefits of pharmacogenomics. However, proper management of data also includes obtaining all the relevant information to maximize beneficence, this being especially important in frontier techniques, such as pharmacogenomics. The purpose of this study is to analyze the main ethical issues in data management in pharmacogenomics, with an emphasis on the way the physician-patient relationship should be developed to maximize relevant data extraction and optimize its management. "

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Z, Mouammine. „Big Data with Distributed Architecture Using Genetic Algorithm in Intelligent Transport Systems“. Journal of Advanced Research in Dynamical and Control Systems 12, SP7 (25.07.2020): 1405–15. http://dx.doi.org/10.5373/jardcs/v12sp7/20202243.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Butil, John Carlo M., Ma Lei Frances Magsisi, John Hart Pua, Prince Kevin Se und Ria Sagum. „The Application of Genetic Algorithm in Motion Detection for Data Storage Optimization“. International Journal of Computer and Communication Engineering 3, Nr. 3 (2014): 199–202. http://dx.doi.org/10.7763/ijcce.2014.v3.319.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Hallinan, Dara, Michael Friedewald und Paul De Hert. „Genetic Data and the Data Protection Regulation: Anonymity, multiple subjects, sensitivity and a prohibitionary logic regarding genetic data?“ Computer Law & Security Review 29, Nr. 4 (August 2013): 317–29. http://dx.doi.org/10.1016/j.clsr.2013.05.013.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Jiang, Rong, Simon Tavaré und Paul Marjoram. „Population Genetic Inference From Resequencing Data“. Genetics 181, Nr. 1 (03.11.2008): 187–97. http://dx.doi.org/10.1534/genetics.107.080630.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Mech, L. David. „Non-Genetic Data Supporting Genetic Evidence for the Eastern Wolf“. Northeastern Naturalist 18, Nr. 4 (Dezember 2011): 521–26. http://dx.doi.org/10.1656/045.018.0409.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Waller, Niels G., und Bengt O. Muth�n. „Genetic tobit factor analysis: Quantitative genetic modeling with censored data“. Behavior Genetics 22, Nr. 3 (Mai 1992): 265–92. http://dx.doi.org/10.1007/bf01066662.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Ziegler, Andreas, Nora Bohossian, Vincent P. Diego und Chen Yao. „Genetic Prediction in the Genetic Analysis Workshop 18 Sequencing Data“. Genetic Epidemiology 38, S1 (11.08.2014): S57—S62. http://dx.doi.org/10.1002/gepi.21826.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!